Pharmaceutical Companies Who Provide Gifts to Doctors Are More Likely to Get Their Drugs Prescribed
A new study is highlighting a long-lauded concern: when doctors are given gifts by pharmaceutical companies, they tend to give patients more "branded" drugs. It's been a theory of those who oppose big pharma's growing influence on the...
Continue reading…
Category: Pharmaceutical
Big Pharma Claims Free Speech allows them to Market Drugs for Off-Label Purposes
Free Speech Is a New Defense for Off-Label Drug Pitches and It’s Having Industry-Wide Ramifications
It’s not unheard of for drugs to be developed for one ailment and be used to treat others. It’s fairly common, after extensive research and testing, for drugs to be used to treat a...
Continue reading…
News investigation reveals that DEA stripped of power by Congress taking millions from drug maker lobbiests
Big Pharma Knows How Laws Work and They Can Use Them Against the DEA
Why did Congress, in the middle of the greatest drug crisis in the nation pass a law that stripped the Drug Enforcement Administration of its ability to sue companies violating drug distribution laws? The answer...
Continue reading…
Avenir Pharma’s marketing of Nuedexta for elderly targeted for investigation
Nuedexta May Have Been Pushed on Elderly Patients According to Pharmaceutical Investigation
The makers of Nuedexta have found themselves in the middle of a far-reaching scandal that could have ties to federal money. According to an in-depth pharmaceutical investigation by CNN, the pill is treating conditions well beyond its FDA approved purpose; their investigation...
Continue reading…
Management individual held liable in Med-Fast Pharmacy whistleblower Medicare fraud case and company pays $2.6 mill.
Med-Fast Pharmacy will pay $2.66 million to settle a False Claims Act case in which the company was charged with submitting claims for medications to Medicare which were not eligible for coverage. The whistleblowers said that the medications for which claims were submitted to the government were either recycled from long-term care facilities or...
Continue reading…
Aegerion Pharma pays $4.1 mill. to settle SEC case on exaggerating sales claims
The Securities and Exchange Commission today filed fraud charges against a Massachusetts-based biopharmaceutical company that exaggerated how many new patients actually filled prescriptions for an expensive drug that was its sole source of revenue.
Aegerion Pharmaceuticals, now a subsidiary of Novelion Therapeutics, has agreed to pay a $4.1 million penalty to settle the charges that...
Continue reading…
Galena Biopharma pays $7.55 mill to end case on kickbacks to docs to induce sales of fentanyl based Abstral
Galena Biopharma will pay more than $7.55 million to resolve allegations that it paid kickbacks to doctors to induce them to prescribe its fentanyl-based drug Abstral. The allegations rose from a whistleblower suit filed under the False Claims Act. "Given the dangers associated with opioids such as Abstral, it is imperative that prescriptions be...
Continue reading…
Novo Nordisk Pharma pays $58.65 million ending DOJ case of not disclosing drug Victoza’s risks to docs
Pharmaceutical Manufacturer Novo Nordisk Inc. will pay $58.65 million to resolve allegations that the company failed to comply with the FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) for its Type II diabetes medication Victoza. Novo Nordisk is a subsidiary of Novo Nordisk U.S. Holdings Inc., which is a subsidiary of Novo Nordisk A/S of...
Continue reading…
Mylan Pharma may have over billed Medicaid for the EpiPen by several hundred million dollars
According to recent news reports Mylan NV may have been paid over one billion more by Medicaid for EpiPen allergic-reaction treatments than it should have from 2006 to 2016. This is more than what Mylan NV said it agreed to pay to settle overcharging allegations. The company said in October to pay $465 million...
Continue reading…
DOJ unveils largest nation-wide health care fraud charges of 412 including 115 doctors and nurses in 12.5 billion fraud in opioids
Largest Health Care Fraud Enforcement Action in Department of Justice History
WASHINGTON – Attorney General Jeff Sessions and Department of Health and Human Services (HHS) Secretary Tom Price, M.D., announced today the largest ever health care fraud enforcement action by the Medicare Fraud Strike Force, involving 412 charged defendants across...
Continue reading…
